PRESS RELEASE published on 06/28/2024 at 09:00, 1 year 7 months ago Q1 2024 Financial Results CannaPharmaRx reports Q1 2024 financial results with revenue commencing. The company anticipates accelerated growth, international expansion, and strategic partnerships Financial Results Revenue Growth Q1 2024 CannapharmaRx
BRIEF published on 05/20/2024 at 19:50, 1 year 9 months ago CannaPharmaRx organisera une conférence téléphonique pour les investisseurs le 21 mai 2024 Mise À Jour Financière Conférence Téléphonique Pour Les Investisseurs Production De Cannabis Doyen Medwid
BRIEF published on 05/20/2024 at 19:50, 1 year 9 months ago CannaPharmaRx to Host Investor Conference Call on May 21, 2024 Investor Conference Call Financial Update Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 19:45, 1 year 9 months ago CORRECTION FROM SOURCE: CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. (OTC PINK:CPMD) will host an investor conference call on May 21, 2024, at 1PM Eastern time to provide updates on financials, products, distribution, and expansion Investor Conference Call Financial Update CannapharmaRx Cannabis Production CPMD
BRIEF published on 05/20/2024 at 18:35, 1 year 9 months ago CannaPharmaRx organisera une conférence téléphonique avec les investisseurs Mise À Jour Financière Conférence Des Investisseurs CannapharmaRx Production De Cannabis Doyen Medwid
BRIEF published on 05/20/2024 at 18:35, 1 year 9 months ago CannaPharmaRx to Host Investor Conference Call Investor Conference Financial Update CannapharmaRx Cannabis Production Dean Medwid
PRESS RELEASE published on 05/20/2024 at 18:30, 1 year 9 months ago CannaPharmaRx to Host Investor Conference Call CannaPharmaRx, Inc. to hold investor conference call on May 21, 2024, providing updates on financials, products, orders, and forecasts. Visit www.cannapharmarx.com for details Investor Conference Call Financial Update CannapharmaRx Cannabis Production Forecasted Revenues
BRIEF published on 04/02/2024 at 12:05, 1 year 10 months ago CannapharmaRx rembourse avec succès les billets convertibles pour renforcer sa position Remboursement De Dette Billets Convertibles CannapharmaRx Production De Cannabis Intérêts Des Actionnaires
BRIEF published on 04/02/2024 at 12:05, 1 year 10 months ago CannapharmaRx Successfully Repays Convertible Notes to Strengthen Position Convertible Notes Debt Repayment Shareholder Interests CannapharmaRx Cannabis Production
PRESS RELEASE published on 04/02/2024 at 12:00, 1 year 10 months ago CannapharmaRx Pays Off Convertible Notes CannapharmaRx, Inc. announces the extinguishment of convertible notes to avoid stock dilution and strengthen the company. CEO Dean Medwid discusses the positive impact on future growth and valuation Convertible Notes Future Growth CannapharmaRx Stock Dilution CEO Dean Medwid
Published on 02/20/2026 at 20:15, 1 hour 32 minutes ago Lithium South Announces Results of its Annual and Special Meeting of Securityholders
Published on 02/20/2026 at 20:15, 1 hour 32 minutes ago Verdera Energy Announces Closing of Qualifying Transaction
Published on 02/20/2026 at 18:30, 3 hours 17 minutes ago Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 6 hours 2 minutes ago Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 7 hours 17 minutes ago Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 18:36, 3 hours 11 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 3 hours 16 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:00, 3 hours 47 minutes ago Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 3 hours 47 minutes ago Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations
Published on 02/20/2026 at 19:29, 2 hours 18 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 2 hours 18 minutes ago SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 3 hours 47 minutes ago TERACT - Résiliation du contrat de liquidité
